Switch to Global Market

Automobiles Swedish Community

Our community narratives are driven by numbers and valuation.

Volvo Car AB (publ.)

VOLCAR B: Execution Risks Will Limit Upside As Competitive Pressures Persist

Key Takeaways Intense EV competition, regulatory uncertainty, and trade barriers are pressuring margins, revenue growth, and cash flow. Heavy investment needs and Chinese market exposure heighten risks to earnings stability and capital allocation.Read more

120

0

0

24

AN

AnalystConsensusTarget

SEK 28.31

8.6% overvalued

AnalystConsensusTarget's Fair Value

Revenue

2.15% p.a.

Profit Margin

4.05%

Future PE

6.74x

Price in 2029

SEK 37.12

Volvo Car AB (publ.)

Chinese Market Risks And Supply Disruptions Will Erode EV Margins

Key Takeaways Downward pricing pressure and overexposure to China threaten Volvo's margins and create significant volatility in revenues and earnings. Heavy investment in electrification and ongoing supply chain disruptions are delaying profitability and increasing operational risks.Read more

9

0

0

0

AN

AnalystLowTarget

SEK 19

61.8% overvalued

AnalystLowTarget's Fair Value

Revenue

0.76% p.a.

Profit Margin

4.31%

Future PE

4.42x

Price in 2029

SEK 24.85

Volvo Car AB (publ.)

Electrification And ADAS Trends Will Redefine Urban Mobility

Key Takeaways Local production ramp-ups and agile regionalization are set to strengthen margins, neutralize trade barriers, and improve profitability as global electrification trends accelerate. Advanced safety tech, in-house software, and a shift toward connected services bolster brand value and enable expansion into high-margin, recurring revenue streams.Read more

19

0

0

2

AN

AnalystHighTarget

SEK 37

16.9% undervalued

AnalystHighTarget's Fair Value

Revenue

4.26% p.a.

Profit Margin

5.81%

Future PE

5.77x

Price in 2028

SEK 48.57

Recently Updated Narratives

AN

andre_santos

Hims & Hers Health - Valuation

Fair Value: US$34.85 13.1% undervalued

1

0

0

CO

composite32

TAV Havalimanlari Holding will soar with €2.5 billion investments fueling future growth

Fair Value: ₺475.51 30.1% undervalued

3

0

0

IN

Lexaria Bioscience's Breakthrough with DehydraTECH to Revolutionize Drug Delivery

Fair Value: US$5.55 85.3% undervalued

1

0

0

Popular Narratives

WE

WealthAP

The "Sleeping Giant" Stumbles, Then Wakes Up

Fair Value: US$82 31.0% undervalued

10.8k

82

6

35

OO

Undervalued Key Player in Magnets/Rare Earth

Fair Value: CA$25.33 22.3% undervalued

7k

68

0

17

AN

AnalystConsensusTarget

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value: US$253.02 26.3% undervalued

10.5k

1038

6

31

Trending Discussion

HO

Holger

<b>Reported:</b> Revenue growth: 2024 → 2025 sharp increase of approx. 165%. Assuming moderate annual growth of 40%, a fair value in three years would be approx. $170. Given the customer base and the story, this should be possible. I find the most valuable “property” particularly interesting, as it solves the electricity problem.

1

|

0

EL

Will certainly invest in this after appropriate DD. Curious what the competitive landacape looks like. As a 10 year crypto guy, QRL - Quantum Resistant Ledger is at about 200M MC and Lockheed Martin has it named in a patent.. so it may not be the only game in town.. but sounds solid.

0

|

0

HE

Hemingway

NVDA+AEVA Agreement is a game changer for the AEVA stock even though it is just a partnership and does not have a roll out until 2028 (which means receivables as early as 2027, I would imagine) This agreement effectively moves the goal posts of profitability for AEVA much closer since this is in addition to the recent Forterra agreement, as well as the (just announced) European carmaker agreement (which is believed to be Mercedes-Benz). Underneath all of this, AEVA has a pre-existing agreement with Daimler truck. So business seems to be booming, especially with really big name brands…which tends to bring in even more brand names (and thus more agreements/contracts/announcements, etc). This dynamic often creates more coverage from analysts (often with upside stock initial coverage) that I believe will be occurring over the next 3 to 6 months (as professional traders/analysts often research for 2 to 3 months before initiating coverage of a new issue). Anyway, this all just one opinion , so please do your own due diligence. Disclaimer: I/We DO trade in this stock from time to time and I/we may (or may not have) a position currently, so again, please do your own due diligence.

0

|

0